Displaying 1-11 of 11 result(s).
| Board Name | Posts By MOTOWN | Post Created |
|---|---|---|
| Investors Hangout MVP's | 6.80 | 12/10/2016 5:04:54 PM |
| BLTA Baltia Air Lines Inc | Stay thirsty my friends  (4) | 12/06/2016 10:10:49 PM |
| BLTA Baltia Air Lines Inc | What a week? We went from naming th (6) | 12/02/2016 8:18:41 PM |
| BLTA Baltia Air Lines Inc | Wouldn't be cool to see who's tell (3) | 11/30/2016 1:19:31 PM |
| BLTA Baltia Air Lines Inc | For some reason I think the perform (2) | 11/28/2016 10:31:24 AM |
| BLTA Baltia Air Lines Inc | I don't really care what they name (5) | 11/27/2016 10:19:54 PM |
| BLTA Baltia Air Lines Inc | https://l.facebook.com/l.php?u= ht (1) | 11/22/2016 9:47:13 PM |
| BLTA Baltia Air Lines Inc | It's 2016 and everyone is awarded a (4) | 11/22/2016 8:10:09 PM |
| BLTA Baltia Air Lines Inc | I thought the red line under my wor | 11/21/2016 9:37:57 PM |
| BLTA Baltia Air Lines Inc | I just went on MSN money and put BL (3) | 11/20/2016 6:27:52 PM |
| BLTA Baltia Air Lines Inc | I've been with BLTA for over a year (3) | 11/15/2016 6:55:42 PM |
Recent Articles
- Steve Eisman's Take on Opendoor's Soaring Stock Price
- Akeso's Ivonescimab Receives NMPA Approval for Lung Cancer Treatment
- Revolutionizing Pet Eye Care: Dômes Pharma and Fear Free Unite
- Samsung's Bold $16.5 Billion Chip Deal to Compete in Tech Sector
- Exploring the Success of CBD Fair Guangzhou's 2025 Edition
- Economic Impact of Trump's Trade Deal: What Comes Next?
- Antengene Prepares for Major Presentation on ATG-022 at ESMO
- How Japan's $550 Billion Deal Can Boost TSMC's Growth in the US
- Hengrui Pharma and GSK Forge Agreement for Advanced Drug Development
- Time Is Running Out for Solar Tax Credit Savings with All Energy Solar
- US and China Seek Trade Solutions Amid Tariff Tensions
- Introducing Automate's Push PRO: Revolutionary Shade Control
- Exciting Esports World Cup Promotion from JBO Thailand
- Harbour BioMed Unveils Strong Profit Predictions for Future Growth
- Ascletis Begins Significant Obesity Study with ASC30 Drug
- Elpis Biopharmaceuticals Partners with NCCS for Groundbreaking Research
- Perseus Mining's Operational Highlights and Financial Overview
- Shara Magomedov Shines at UFC Night with Epic Victory
- Investors Urged to Participate in Class Action Against Centene
- Exploring America’s Hidden Resource Potential and Technology
- Trump's New Tariff Deal with EU: Impacts and Insights
- Shaquille O'Neal's Hilarious Showdown with Jimmy Kimmel
- Empowering Hims & Hers Health Shareholders: Your Legal Guide
- Public Sentiment on Trump's Tax Cuts: A Closer Look
- Innovative Cooling Solutions Pioneered by i2Cool for a Sustainable Future
- Easterly ROCMuni Fund Class Action: Investor Rights Explained
- Class Action Alert: RxSight Investors Take Action Against Losses
- Investors of iRobot Corporation Urged to Act Before Deadline
- Dustin Moskovitz Expands Asana Holdings with Major Purchase
- Navigating High-Stress Careers: Insights from Executives
- Banco Comercial Português Updates on Share Buy-Back Programme Activity
- Centene Corporation Faces Class Action Over Investor Losses
- Banco Comercial Português (BCP) Shares Buy-Back Program Update
- Insights into Gilead Sciences, Inc. and Recent Developments
- Legal Action Initiated Against Flywire Corporation's Officers
- Replimune Group Faces Legal Action Amid Stock Price Decline
- Investors Seek Clarity on Simulations Plus Financial Concerns
- Shocking Survey: How Much Would You Sacrifice For Wealth?
- Harnessing Natural Testosterone Boosters for Optimal Muscle Growth
- Neuralink’s Recent Developments and Future Aspirations Explained
- Global AI Cooperation: China's Vision for the Future of Technology
- Investment Insights from Experts: Maximize Your $10,000 Now
- Shiba Inu's 3,000% Growth Potential in Competitive Memecoin Market
- Investors Seek Justice in Biohaven Ltd. Class Action Lawsuit
- Class Action Lawsuit Against Hims & Hers Health, Inc. Explained
- Sarepta Therapeutics Faces Legal Challenges Amidst Controversies
- Investors Take Note: Class Actions Against Western Asset Management
- Mereo BioPharma Faces Scrutiny as Investigation Unfolds
- Centene Corporation Faces Class Action Lawsuit Amidst Losses
- Investigation Unfolds for Capricor Therapeutics Amid Stock Fluctuations